We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYY icon
551
Sysco
SYY
$41.1B
$2.04M 0.01%
26,634
-2,593
-9% -$209K
AMED
552
DELISTED
Amedisys
AMED
$2.03M 0.01%
24,310
+2,028
+9% +$183K
YUMC icon
553
Yum China
YUMC
$15.9B
$2.03M 0.01%
8,700
-1,200
-12% -$61K
ETSY icon
554
Etsy
ETSY
$8.14B
$2.01M 0.01%
16,749
-55,884
-77% -$6.39M
ESS icon
555
Essex Property Trust
ESS
$19B
$2M 0.01%
9,431
-1,004
-10% -$219K
JBGS
556
JBG SMITH
JBGS
$859M
$1.99M 0.01%
+105,000
New +$2.03M
MNST icon
557
Monster Beverage
MNST
$95.5B
$1.98M 0.01%
39,018
-1,658
-4% -$80.3K
UNFI icon
558
United Natural Foods
UNFI
$3.08B
$1.97M 0.01%
50,969
+17,055
+50% +$706K
SBAC icon
559
SBA Communications
SBAC
$18.8B
$1.97M 0.01%
7,012
-337
-5% -$93.8K
NIO icon
560
NIO
NIO
$12B
$1.95M 0.01%
200,000
– –
BR icon
561
Broadridge
BR
$18.7B
$1.94M 0.01%
14,427
-1,762
-11% -$250K
IBN icon
562
ICICI Bank
IBN
$107B
$1.93M 0.01%
88,000
+28,000
+47% +$624K
ONEM
563
DELISTED
1Life Healthcare
ONEM
$1.91M 0.01%
114,440
– –
MRO
564
DELISTED
Marathon Oil Corporation
MRO
$1.9M 0.01%
70,289
-52,091
-43% -$1.51M
NGM
565
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1.89M 0.01%
376,162
+92,112
+32% +$577K
WRB icon
566
W.R. Berkley
WRB
$28.2B
$1.87M 0.01%
38,664
-3,525
-8% -$170K
RVTY icon
567
Revvity
RVTY
$12.4B
$1.87M 0.01%
13,313
-4,206
-24% -$566K
IRM icon
568
Iron Mountain
IRM
$35.9B
$1.87M 0.01%
37,416
-4,304
-10% -$217K
MRVI icon
569
Maravai LifeSciences
MRVI
$953M
$1.86M 0.01%
+130,000
New +$2.05M
SPLK
570
DELISTED
Splunk Inc
SPLK
$1.84M 0.01%
21,324
-748
-3% -$60.4K
STOR
571
DELISTED
STORE Capital Corporation
STOR
$1.83M 0.01%
57,134
– –
RELX icon
572
RELX
RELX
$67B
$1.82M 0.01%
65,552
+1,528
+2% +$41.1K
DOW icon
573
Dow Inc
DOW
$21.8B
$1.81M 0.01%
35,990
+12,232
+51% +$598K
AIMC
574
DELISTED
Altra Industrial Motion Corp
AIMC
$1.8M 0.01%
+30,152
New +$1.58M
CINF icon
575
Cincinnati Financial
CINF
$27.7B
$1.8M 0.01%
17,590
-5,450
-24% -$561K
21 22
23
24 25

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.